O Salvatierra
Overview
Explore the profile of O Salvatierra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li L, Khatri P, Sigdel T, Tran T, Ying L, Vitalone M, et al.
Am J Transplant
. 2012 Sep;
12(10):2710-8.
PMID: 23009139
Monitoring of renal graft status through peripheral blood (PB) rather than invasive biopsy is important as it will lessen the risk of infection and other stresses, while reducing the costs...
2.
Sarwal M, Ettenger R, Dharnidharka V, Benfield M, Mathias R, Portale A, et al.
Am J Transplant
. 2012 Jun;
12(10):2719-29.
PMID: 22694755
To determine whether steroid avoidance in pediatric kidney transplantation is safe and efficacious, a randomized, multicenter trial was performed in 12 pediatric kidney transplant centers. One hundred thirty children receiving...
3.
Naesens M, Salvatierra O, Benfield M, Ettenger R, Dharnidharka V, Harmon W, et al.
Am J Transplant
. 2012 Jun;
12(10):2730-43.
PMID: 22694733
Steroid avoidance is safe and effective in children receiving kidney transplants in terms of graft function and survival, but the effects on allograft histology are unknown. In this multicenter trial,...
4.
Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, et al.
Am J Transplant
. 2009 May;
9(6):1362-72.
PMID: 19459814
Despite early promising patient and graft outcomes with steroid-free (SF) immunosuppression in pediatric kidney transplant recipients, data on long-term safety and efficacy results are lacking. We present our single-center experience...
5.
Zarkhin V, Li L, Kambham N, Sigdel T, Salvatierra O, Sarwal M
Am J Transplant
. 2008 Sep;
8(12):2607-17.
PMID: 18808404
We report 1-year outcomes of a randomized study of Rituximab versus standard-of-care immunosuppression (Thymoglobulin and/or pulse steroids) for treatment of biopsy confirmed, acute transplant rejection with B-cell infiltrates, in 20...
6.
Li L, Weintraub L, Concepcion W, Martin J, Miller K, Salvatierra O, et al.
Pediatr Transplant
. 2008 Jan;
12(6):701-7.
PMID: 18179640
With the increasing adoption of steroid-sparing immunosuppression protocols in renal transplantation, it is important to evaluate any adverse effects of steroid avoidance on graft function. Early graft function, measured by...
7.
Belson A, Yorgin P, Salvatierra O, Higgins J, Alexander S
Pediatr Nephrol
. 2002 Jan;
16(12):985-9.
PMID: 11793085
Transient or intermittent plasmapheresis with concurrent immunosuppressive therapy is thought to be beneficial in the treatment of recurrent focal segmental glomerulosclerosis (FSGS) in the early post-transplant period. The results of...
8.
9.
Sarwal M, Chang S, Barry C, Chen X, Alizadeh A, Salvatierra O, et al.
Transplant Proc
. 2001 Mar;
33(1-2):297-8.
PMID: 11266826
No abstract available.
10.